From Casetext: Smarter Legal Research

Chapman v. Fennec Pharm.

United States District Court, Middle District of North Carolina
Mar 2, 2022
1:20CV812 (M.D.N.C. Mar. 2, 2022)

Opinion

1:20CV812

03-02-2022

JIM CHAPMAN, Individually and on Behalf of All Others Similarly Situated, Plaintiff, v. FENNEC PHARMACEUTICALS INC., et al., Defendants.


ORDER

Loretta C. Biggs United States District Judge

The Order and Recommendation of the United States Magistrate Judge was filed with the court in accordance with 28 U.S.C. § 636(b) and, on December 16, 2021, was served on the parties in this action. (ECF Nos. 48, 49). Lead Plaintiff Daniel Malakoti filed an objection to the Recommendation. (ECF No. 55).

The court has appropriately reviewed the portions of the Magistrate Judge's report to which objection was made and has made a de novo determination which is in accord with the Magistrate Judge's report. The court therefore adopts the Magistrate Judge's recommendation.

IT IS THEREFORE ORDERED that Defendants' Motion to Dismiss, (ECF No. 40), is GRANTED as to Lead Plaintiff Daniel Malakoti's Consolidated Amended Class Action Complaint asserting claims of securities fraud in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Securities and Exchange Commission Rule 10b-5, and that this action is DISMISSED with prejudice.

A judgment dismissing this action will be entered contemporaneously with this Order.


Summaries of

Chapman v. Fennec Pharm.

United States District Court, Middle District of North Carolina
Mar 2, 2022
1:20CV812 (M.D.N.C. Mar. 2, 2022)
Case details for

Chapman v. Fennec Pharm.

Case Details

Full title:JIM CHAPMAN, Individually and on Behalf of All Others Similarly Situated…

Court:United States District Court, Middle District of North Carolina

Date published: Mar 2, 2022

Citations

1:20CV812 (M.D.N.C. Mar. 2, 2022)

Citing Cases

Sorensson v. Dollar Gen. Corp.

; Chapman v. Fennec Pharms. Inc., No. 1:20CV812, 2021 WL 7209981, at *4 (M.D. N.C. Dec. 16, 2021), mem. &…